Zeaxanthin inhibits PDGF-BB-induced migration in human dermal fibroblasts

Experimental Dermatology

Volumn 19, Issue 8, 2010, Pages

  Wu, Nan Lin ^a,b   Chiang, Yuh Chiau ^c   Huang, Chieh Chen ^d,e   Fang, Jia You ^f   Chen, Der Fang ^g   Hung, Chi Feng ^d  

^a MACKAY MEMORIAL HOSPITAL   (Taiwan)

^b NURSING AND MANAGEMENT COLLEGE   (Taiwan)

^c TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^d FU JEN CATHOLIC UNIVERSITY   (Taiwan)

^e SHIN KONG WU HO SU MEMORIAL HOSPITAL   (Taiwan)

^f CHANG GUNG UNIVERSITY   (Taiwan)

^g CATHAY GENERAL HOSPITAL   (Taiwan)

Author keywords

Fibroblast; Melanoma; Migration; PDGF BB; Zeaxanthin

Indexed keywords

MITOGEN ACTIVATED PROTEIN KINASE; ZEAXANTHIN;

ARTICLE; CELL CULTURE; CELL FUNCTION; CELL MIGRATION; CELL VIABILITY; DOSE RESPONSE; DRUG EFFECT; DRUG INHIBITION; FIBROBLAST; HUMAN; HUMAN CELL; MELANOMA; WOUND HEALING;

CELL COMMUNICATION; CELL LINE; CELL LINE, TUMOR; CELL MOVEMENT; CELL SURVIVAL; CELLS, CULTURED; COCULTURE TECHNIQUES; FIBROBLASTS; HUMANS; MALE; MELANOMA; MITOGEN-ACTIVATED PROTEIN KINASE KINASES; PLATELET-DERIVED GROWTH FACTOR; SIGNAL TRANSDUCTION; SKIN; SKIN NEOPLASMS; WOUND HEALING; XANTHOPHYLLS;

EID: 77954836545     PISSN: 09066705     EISSN: 16000625     Source Type: Journal    
DOI: 10.1111/j.1600-0625.2009.01036.x     Document Type: Article

References (37)

1. USDA-NCC Carotenoid Database for U.S. Foods - 1998 1998, In
2. Ojima F, Sakamoto H, Ishiguro Y, Terao J. Consumption of carotenoids in photosensitized oxidation of human plasma and plasma low-density lipoprotein. Free Radic Biol Med 1993, 15:377-384.
3. Seddon J M, Ajani U A, Sperduto R D. Dietary carotenoids, vitamins A, C, and E, and advanced age-related macular degeneration. Eye Disease Case-Control Study Group. JAMA 1994, 272:1413-1420.
4. Ribaya-Mercado J D, Blumberg J B. Lutein and zeaxanthin and their potential roles in disease prevention. J Am Coll Nutr 2004, 23:567S-587S.
5. Mignone L I, Giovannucci E, Newcomb P A. Dietary carotenoids and the risk of invasive breast cancer. Int J Cancer 2009, 124:2929-2937.
6. Persson C, Sasazuki S, Inoue M. Plasma levels of carotenoids, retinol and tocopherol and the risk of gastric cancer in Japan: a nested case-control study. Carcinogenesis 2008, 29:1042-1048.
7. Heinen M M, Hughes M C, Ibiebele T I, Marks G C, Green A C, van der Pols J C. Intake of antioxidant nutrients and the risk of skin cancer. Eur J Cancer 2007, 43:2707-2716.
8. Joyce J A, Pollard J W. Microenvironmental regulation of metastasis. Nat Rev Cancer 2009, 9:239-252.
9. Liotta L A, Steeg P S, Stetler-Stevenson W G. Cancer metastasis and angiogenesis: an imbalance of positive and negative regulation. Cell 1991, 64:327-336.
10. Fidler I J. Modulation of the organ microenvironment for treatment of cancer metastasis. J Natl Cancer Inst 1995, 87:1588-1592.
11. Ruiter D, Bogenrieder T, Elder D, Herlyn M. Melanoma-stroma interactions: structural and functional aspects. Lancet Oncol 2002, 3:35-43.
12. Lee J T, Herlyn M. Microenvironmental influences in melanoma progression. J Cell Biochem 2007, 101:862-872.
13. Li W, Fan J, Chen M. Mechanism of human dermal fibroblast migration driven by type I collagen and platelet-derived growth factor-BB. Mol Biol Cell 2004, 15:294-309.
14. Heldin C H, Westermark B. Mechanism of action and in vivo role of platelet-derived growth factor. Physiol Rev 1999, 79:1283-1316.
15. Seppa H, Grotendorst G, Seppa S, Schiffmann E, Martin G R. Platelet-derived growth factor in chemotactic for fibroblasts. J Cell Biol 1982, 92:584-588.
16. Takehara K. Growth regulation of skin fibroblasts. J Dermatol Sci 2000, 24(Suppl. 1):S70-S77.
17. Andrae J, Gallini R, Betsholtz C. Role of platelet-derived growth factors in physiology and medicine. Genes Dev 2008, 22:1276-1312.
18. Pietras K, Sjoblom T, Rubin K, Heldin C H, Ostman A. PDGF receptors as cancer drug targets. Cancer Cell 2003, 3:439-443.
19. Chiang H S, Wu W B, Fang J Y. Lycopene inhibits PDGF-BB-induced signaling and migration in human dermal fibroblasts through interaction with PDGF-BB. Life Sci 2007, 81:1509-1517.
20. Wu W B, Chiang H S, Fang J Y, Hung C F. Inhibitory effect of lycopene on PDGF-BB-induced signalling and migration in human dermal fibroblasts: a possible target for cancer. Biochem Soc Trans 2007, 35:1377-1378.
21. Huang C C, Fang J Y, Wu W B, Chiang H S, Wei Y J, Hung C F. Protective effects of (-)-epicatechin-3-gallate on UVA-induced damage in HaCaT keratinocytes. Arch Dermatol Res 2005, 296:473-481.
22. Hung C F, Huang T F, Chiang H S, Wu W B. (-)-Epigallocatechin-3-gallate, a polyphenolic compound from green tea, inhibits fibroblast adhesion and migration through multiple mechanisms. J Cell Biochem 2005, 96:183-197.
23. Stevenson S, Sharpe D T, Julie Thornton M. Effects of oestrogen agonists on human dermal fibroblasts in an in vitro wounding assay. Exp Dermatol 2009, 18:988-990.
24. Wiederholt T, Heise R, Skazik C. Calcium pantothenate modulates gene expression in proliferating human dermal fibroblasts. Exp Dermatol 2009, 18:969-978.
25. Lee J F, Zeng Q, Ozaki H. Dual roles of tight junction-associated protein, zonula occludens-1, in sphingosine 1-phosphate-mediated endothelial chemotaxis and barrier integrity. J Biol Chem 2006, 281:29190-29200.
26. Chan C M, Fang J Y, Lin H H, Yang C Y, Hung C F. Lycopene inhibits PDGF-BB-induced retinal pigment epithelial cell migration by suppression of PI3K/Akt and MAPK pathways. Biochem Biophys Res Commun 2009, 388:172-176.
27. Lo H M, Hung C F, Tseng Y L, Chen B H, Jian J S, Wu W B. Lycopene binds PDGF-BB and inhibits PDGF-BB-induced intracellular signaling transduction pathway in rat smooth muscle cells. Biochem Pharmacol 2007, 74:54-63.
28. Hughes A D, Clunn G F, Refson J, Demoliou-Mason C. Platelet-derived growth factor (PDGF): actions and mechanisms in vascular smooth muscle. Gen Pharmacol 1996, 27:1079-1089.
29. Tallquist M, Kazlauskas A. PDGF signaling in cells and mice. Cytokine Growth Factor Rev 2004, 15:205-213.
30. van Kempen L C, Ruiter D J, van Muijen G N, Coussens L M. The tumor microenvironment: a critical determinant of neoplastic evolution. Eur J Cell Biol 2003, 82:539-548.
31. Bennicelli J L, Guerry D T. Production of multiple cytokines by cultured human melanomas. Exp Dermatol 1993, 2:186-190.
32. Svegliati S, Cancello R, Sambo P. Platelet-derived growth factor and reactive oxygen species (ROS) regulate Ras protein levels in primary human fibroblasts via ERK1/2. Amplification of ROS and Ras in systemic sclerosis fibroblasts. J Biol Chem 2005, 280:36474-36482.
33. Meng T C, Fukada T, Tonks N K. Reversible oxidation and inactivation of protein tyrosine phosphatases in vivo. Mol Cell 2002, 9:387-399.
34. Saito Y, Haendeler J, Hojo Y, Yamamoto K, Berk B C. Receptor heterodimerization: essential mechanism for platelet-derived growth factor-induced epidermal growth factor receptor transactivation. Mol Cell Biol 2001, 21:6387-6394.
35. Kappert K, Sparwel J, Sandin A. Antioxidants relieve phosphatase inhibition and reduce PDGF signaling in cultured VSMCs and in restenosis. Arterioscler Thromb Vasc Biol 2006, 26:2644-2651.
36. O'Connor I, O'Brien N. Modulation of UVA light-induced oxidative stress by beta-carotene, lutein and astaxanthin in cultured fibroblasts. J Dermatol Sci 1998, 16:226-230.
37. Nakajima Y, Shimazawa M, Otsubo K, Ishibashi T, Hara H. Zeaxanthin, a retinal carotenoid, protects retinal cells against oxidative stress. Curr Eye Res 2009, 34:311-318.